(435) 292-5548
 Medicare News
Home  ›  Prescription Assistance  ›  Breo Ellipta

COPD & Asthma

Breo Ellipta Assistance Programs & Grants

Assistance information last verified: August 2026

AltaMedicare is an independent Medicare agency in Alpine, Utah, founded by Bret Swope, a licensed Medicare agent. We provide educational, no-pressure help comparing Medicare Advantage, Medigap (Medicare Supplement), and Part D at no cost, serving the entire state of Utah. Call or text (435) 292-5548.

Manufacturer programs, charitable grants and Medicare routes for Breo Ellipta (fluticasone furoate / vilanterol) — each checked on its official source.

Can I get help paying for Breo Ellipta?

Yes — GSK runs a patient assistance program that covers Breo Ellipta and has a genuine Medicare pathway, but that pathway has a condition most people do not expect: you must already have paid $600 for prescriptions this calendar year. Both charitable funds that list Breo were closed. And from January 1, 2027 Medicare's own negotiated price of $67.00 per 30-day supply applies.

  • GSK Patient Assistance Program: Breo Ellipta is on the published list of eligible products. The Medicare route requires a Medicare drug plan, income at or below $47,880 for one person, and $600 already spent on prescriptions this calendar year.
  • Medicare negotiated price: $67.00 per 30-day equivalent supply, effective January 1, 2027 (CMS selected-drug file, IPAY 2027).
  • Authorized generic: Prasco Laboratories labels fluticasone furoate and vilanterol inhalation powder. Ask your prescriber and plan whether it is on your formulary at a lower tier.
  • No GSK copay program: Breo is not on GSK's copay-assistance list, and its dollars-off coupon cannot be used by anyone with Medicare. GSK Direct to You does not offer Breo either.
  • Charitable grants: TotalAssist's COPD and Asthma funds both list Breo Ellipta and both were closed, each with a $1,200 guaranteed and $3,500 maximum award. HealthWell's Asthma and COPD funds were closed too, and Good Days has no respiratory fund at all.

2 of the 7 programs we checked for Breo Ellipta were accepting applications when verified in August 2026.

About Breo Ellipta (fluticasone furoate / vilanterol)

Breo Ellipta is a once-daily maintenance inhaler that combines an inhaled steroid with a long-acting bronchodilator. It is one of the few inhalers licensed for both COPD and asthma, and from January 1, 2027 it is also one of the small number of medications for which Medicare has negotiated a price directly with the manufacturer.

Approved uses

  • Maintenance treatment of chronic obstructive pulmonary disease (COPD), to improve airflow and reduce flare-ups
  • Maintenance treatment of asthma in patients aged 5 years and older

Manufacturer: GSK (GlaxoSmithKline)

Why Breo Ellipta can be expensive on Medicare

Breo Ellipta is a once-daily brand inhaler that most Part D plans place on a brand tier, often behind step therapy that asks you to try a cheaper inhaler first. Two things pull the other way, and both are specific to this medication. Medicare negotiated its price: CMS set a maximum fair price of $67.00 for a 30-day equivalent supply, effective January 1, 2027. And an authorized generic now exists — DailyMed labels fluticasone furoate and vilanterol inhalation powder from Prasco Laboratories alongside GSK's brand, which is not true of every inhaler on this site.

Medicare coverage context

Breo Ellipta is an inhaler you use yourself, so Medicare covers it under Part D or a Medicare Advantage drug plan. It is one of the 15 drugs CMS selected for the second cycle of Medicare drug price negotiation: the maximum fair price is $67.00 per 30-day equivalent supply and it takes effect on January 1, 2027 for people whose Part D plans cover it. A negotiated price is not a cash price — it changes what plans and enrollees pay, not what a pharmacy charges someone paying out of pocket. Part D out-of-pocket costs are capped at $2,100 in 2026, Extra Help lowers cost-sharing for people with limited income and resources, and the Medicare Prescription Payment Plan can spread what you owe across the year.

Check typical Part D coverage · Estimate your drug costs · Compare Part D drug plans

Breo Ellipta assistance options at a glance

Every program we checked, what kind of help it is, whether people with Medicare can use it, and its status when we verified it. A medication being listed by a program is not the same as the program accepting applications.

About the income limits below: Income limits can differ between assistance programs even when both describe their eligibility as the same percentage of the federal poverty level. The dollar limits shown here come from each program's own published income table, and each program decides which year's poverty guidelines that table is built from and when it takes effect. Treat the figures as belonging to the program they are listed under — they are not interchangeable, and only the program can tell you which table it is applying to your application today.

Breo Ellipta assistance programs compared
ProgramType of helpPeople with MedicareStatus (August 2026)
GSK Patient Assistance Program Manufacturer patient assistance with conditions Accepting applications
GSK copay assistance — Breo Ellipta not covered Commercial copay / savings card not eligible No program found
Breo Ellipta dollars-off coupon Commercial copay / savings card not eligible Open with limits
GSK Direct to You — Breo Ellipta not offered Manufacturer self-pay pricing not stated No program found
TotalAssist — COPD and Asthma funds Charitable grant may apply Closed to new applicants
HealthWell Foundation — Asthma and COPD funds Charitable grant may apply Closed to new applicants
Good Days — no applicable fund Charitable grant not stated No program found
Medicare Extra Help (Part D Low-Income Subsidy) Government program may apply Accepting applications

Manufacturer programs from GSK (GlaxoSmithKline)

A patient assistance program (free or low-cost drug by income) is not the same as a copay card (a commercial discount that usually excludes Medicare). Both are listed so you can see which one applies to you.

Manufacturer patient assistance

GSK Patient Assistance Program

GSK Patient Access Programs Foundation (an independent 501(c)(3) charitable foundation)

Accepting applications Medicare: with conditions

Status: Accepting applications on August 26, 2026. Breo Ellipta appears on the program's published "List of eligible products", which names 20 GSK medicines.

The GSK Patient Access Programs Foundation supplies certain GSK medicines at no cost to people who meet its income and insurance rules. Breo Ellipta is one of them. This is a genuine free-medicine program, not a discount card.

If you have Medicare: Medicare beneficiaries may apply, but through a separate route with an extra condition. For the "general" category of GSK medicines — which is where Breo Ellipta sits — you must have a Medicare prescription drug plan AND "have paid a total of $600 for prescriptions in the current calendar year". That spending threshold is the single most important thing to know before applying, and it is why an application in January is usually premature and one later in the year often is not. Note that GSK applies a different rule to its specialty medicines: Nucala, from the same foundation, has no $600 requirement but excludes anyone enrolled in Extra Help. Do not carry one rule across to the other.

What it can cover: Breo Ellipta at no cost to approved patients, supplied through the program.

Who may qualify

  • Live in the United States or Puerto Rico
  • Have a Medicare prescription drug plan and meet the program's other requirements
  • Have paid a total of $600 for prescriptions in the current calendar year
  • Maximum annual gross income (48 states and DC): $47,880 for one person, $64,920 for two, $81,960 for three, $99,000 for four, adding $17,040 for each additional person
  • Higher income limits apply in Alaska ($59,850 for one person) and Hawaii ($55,080); Puerto Rico limits are lower ($28,800)
  • Not eligible for Puerto Rico's Government Health Plan Mi Salud, or have applied and been denied

What the application asks for

  • Proof of income for your household
  • Your Medicare prescription drug plan details
  • Records of what you have paid for prescriptions this calendar year, for the $600 threshold
  • Your prescriber's details — GSK's enrollment forms are signed by both patient and provider

How to apply

Start at the GSK Patient Assistance Program page and follow the Medicare route for prescription medicines. The enrollment form is completed and signed by both you and your prescriber. Call 1-866-728-4368 with questions; that line also handles refills once you are enrolled.

GSK Patient Assistance — Medicare eligibility → 1-866-728-4368

Commercial copay / savings card

GSK copay assistance — Breo Ellipta not covered

GSK

No program found Medicare: not eligible

Status: GSK runs copay programs for seven medicines on August 26, 2026 — Benlysta, Blenrep, Exdensur, Jemperli, Nucala, Ojjaara and Zejula. Breo Ellipta is not among them.

An honest negative. Breo Ellipta has a dollars-off coupon rather than a copay program, and a coupon is not usable with Medicare. The GSK route that does work for a Medicare beneficiary is the patient assistance program above.

If you have Medicare: Academic for Breo, since no copay program exists for it, but worth stating plainly because the two facts are easy to confuse: GSK's copay programs require that "You're not eligible for, or enrolled in, a government-funded program", so they exclude Medicare across the board. GSK directs people with Medicare to the patient assistance foundation instead — which for Breo is the correct route.

How to apply

Not applicable. If GSK adds Breo Ellipta to its copay programs it would appear on the copay-assistance page cited here.

GSK copay assistance →

Commercial copay / savings card

Breo Ellipta dollars-off coupon

GSK

Open with limits Medicare: not eligible

Status: Listed on GSK's coupons page on August 26, 2026 alongside Advair, Anoro, Arnuity, Incruse, Serevent, Trelegy and Ventolin. GSK publishes no dollar value for it — the amount is shown only through the site's coupon finder — so no figure is reproduced here. GSK also states it is "not currently offering any free trial offers".

A commercial discount for people with private or employer prescription insurance. If you have Medicare this is not your route, and knowing that saves a trip to the pharmacy counter.

If you have Medicare: GSK's terms are explicit: the coupon "may not be used by government beneficiaries, including but not limited to those enrolled in Medicare or Medicaid." This is the standard federal anti-kickback position on manufacturer coupons and it applies regardless of the coupon's value.

Who may qualify

  • Commercial (private or employer-sponsored) prescription insurance
  • Not enrolled in Medicare, Medicaid or another government prescription program

How to apply

Commercially insured patients can use the coupon finder on GSK's coupons page. Medicare beneficiaries should apply to the GSK Patient Assistance Program instead.

GSK coupons and offers →

Manufacturer self-pay pricing

GSK Direct to You — Breo Ellipta not offered

GSK (dispensed by Alto Pharmacy)

No program found Medicare: not stated

Status: On August 26, 2026 GSK Direct to You offered Advair Diskus, Advair HFA, Anoro Ellipta, Arnuity Ellipta, Incruse Ellipta, Malarone, Relenza and Ventolin HFA at published cash prices. Breo Ellipta was not on the list.

An honest negative worth checking, because GSK does sell two of its other COPD inhalers direct at published prices — Anoro Ellipta at $222.94 and Incruse Ellipta at $134.20, plus a processing and shipping fee of up to $25. There is no equivalent cash price for Breo.

If you have Medicare: Not applicable — Breo is not part of the program, so it states no Medicare rule. For the inhalers GSK does offer this way, the terms say "This Offer is not available to patients who wish to use insurance," which makes it a cash alternative rather than a Part D benefit.

How to apply

Not applicable. If GSK adds Breo Ellipta it would appear on the Direct to You product list cited here.

GSK Direct to You → (800) 874-5881

Charitable grants for Breo Ellipta

Breo Ellipta is named on more charitable funds than most inhalers on this site, because its label covers both COPD and asthma and the foundations run separate funds for each. TotalAssist lists it on its COPD fund, its Asthma fund and the health-equity version of both — four funds, all closed on August 26, 2026, each paying a $1,200 guaranteed award up to $3,500. HealthWell runs an Asthma fund and a COPD – Medicare Access fund and both were closed as well. Good Days has no respiratory fund at all. Set alerts on TotalAssist and HealthWell, because with six closed funds between them the odds that one reopens are better than average — but do not build your year around it. The routes that do not depend on a fund balance are GSK's patient assistance program, the authorized generic, Extra Help, and Medicare's negotiated price from January 2027.

Charitable grant

TotalAssist — COPD and Asthma funds

Patient Advocate Foundation · Chronic obstructive pulmonary disease (COPD) · Asthma · and the health-equity version of each

Closed to new applicants Medicare: may apply

Status: All four applicable funds were closed to new applicants on August 26, 2026, each with a $1,200 guaranteed and $3,500 maximum award. TotalAssist has no waitlist, so the notification sign-up is what gets you in when one reopens.

Breo Ellipta is unusual in being named on both the COPD and the Asthma approved-medication lists, which reflects its dual indication. That means two funds to watch rather than one — but on the checked date both were closed, as were their health-equity counterparts.

If you have Medicare: These funds require government-insured coverage — Medicare, Medicaid or TRICARE — that covers your qualifying expenses. Medicare beneficiaries are eligible when a fund is open.

What it can cover: When open: $1,200 guaranteed award and up to $3,500 maximum for medication copays, coinsurance, deductibles and health-insurance premiums. One grant per condition.

Who may qualify

  • Confirmed COPD or asthma diagnosis, in treatment, starting within 60 days, or treated in the past 6 months
  • Government-insured coverage (Medicare, Medicaid or TRICARE) that covers your qualifying expenses
  • Household income at or below 500% of the federal poverty level, adjusted for your regional cost-of-living index
  • Confirmed diagnosis matching the fund, and in treatment (or starting within 60 days, or treated in the past 6 months)
  • Legal U.S. resident receiving treatment in the U.S. or a U.S. territory
  • The health-equity funds additionally require a home zip code in a designated social-vulnerability county

What the application asks for

  • Contact information and Social Security number (or alien number)
  • Annual household income (for pre-screening; proof of income due within 30 days of approval)
  • Health insurance carrier, plan type, policy ID and group number; Medicare supplement or secondary insurance if you have one
  • Copay or coinsurance amounts
  • Your provider's name and contact information, diagnosis (exact date if within 6 months), prescribed medications and treatment plan

How to apply

Sign up for fund notifications (text, email or automated call) at totalassist.org/notify. When a fund opens: You (the patient) apply online — it takes about 15 minutes and you learn immediately whether you are approved — or call 866-512-3861, Monday–Friday 8:30am–5:30pm ET. Patient Advocate Foundation verifies your diagnosis and treatment plan directly with your provider and verifies income automatically; you have 30 days after approval to provide proof of income.

Get notified when a TotalAssist fund opens → 866-512-3861

Charitable grant

HealthWell Foundation — Asthma and COPD funds

HealthWell Foundation · Asthma · Chronic Obstructive Pulmonary Disease – Medicare Access

Closed to new applicants Medicare: may apply

Status: Both respiratory funds were closed on August 26, 2026. The only open lung fund on HealthWell's published list was Bronchiectasis, which is a different diagnosis and would not apply to a Breo prescription written for COPD or asthma.

HealthWell runs funds for both of Breo's indications and both were closed. HealthWell says replenished funds reopen as quickly as possible and offers real-time alerts, which is the practical move here.

If you have Medicare: HealthWell accepts Medicare beneficiaries, and its COPD fund is a "Medicare Access" fund — designed specifically for people with Medicare. That makes it worth an alert even though it was closed when we checked.

What it can cover: When open: copays, coinsurance, deductibles and health-insurance premiums for the covered diagnosis.

Who may qualify

  • A confirmed asthma or COPD diagnosis, verified by your prescriber
  • Some form of health insurance (Medicare qualifies) that covers part of the cost of the drug — discount cards do not count
  • Social Security number (used to prevent duplicate applications)
  • Diagnosis verified by a physician's, nurse practitioner's or physician assistant's signature
  • Treatment in the United States

What the application asks for

  • Some form of health insurance (Medicare qualifies) that covers part of the cost of the drug — discount cards do not count
  • Social Security number (used to prevent duplicate applications)
  • Diagnosis verified by a physician's, nurse practitioner's or physician assistant's signature
  • Treatment in the United States

How to apply

When a fund is open, apply online or by phone; your provider verifies the diagnosis by signature. When a fund is closed, sign up for that fund's real-time alerts — HealthWell says replenished funds reopen "as quickly as possible."

HealthWell disease funds and alerts → (800) 675-8416

Charitable grant

Good Days — no applicable fund

Good Days

No program found Medicare: not stated

Status: Good Days' published disease list on August 26, 2026 contained 57 programs and none of them was asthma or COPD.

An honest negative, checked so you do not spend time on a third foundation that has no fund for you.

If you have Medicare: Good Days accepts Medicare beneficiaries for the diseases it covers, but it covers no diagnosis that would apply to Breo Ellipta.

How to apply

Not applicable today. The diseases-covered page shows every fund Good Days runs.

Good Days diseases covered →

How to apply for Breo Ellipta assistance

  1. Step 1 — Find the applicable assistance program

    For Breo Ellipta on Medicare in August 2026 there is a real manufacturer route, which is not true of every inhaler on this site. The order that saves the most time:

    • Limited income and you have already spent $600 on prescriptions this year → the GSK Patient Assistance Program.
    • Limited income and resources → Medicare Extra Help through Social Security, which is worth applying for regardless.
    • Ask your prescriber and plan about the Prasco authorized generic of fluticasone furoate and vilanterol.
    • COPD or asthma diagnosis → set alerts on the TotalAssist and HealthWell funds (all closed when checked).
    • Commercial insurance instead of Medicare → the GSK coupon, which Medicare enrollees cannot use.

  2. Step 2 — Check whether applications are currently open

    One manufacturer program to check and six charitable funds whose status changes without notice.

    • GSK Patient Assistance: the eligible-products list and the Medicare eligibility page are the authoritative sources, and both are cited on this page.
    • TotalAssist: the COPD and Asthma fund pages each show "Open" or "Closed" and the current award amounts.
    • HealthWell: the disease-funds list shows the Asthma and COPD – Medicare Access funds and their status.

  3. Step 3 — Check eligibility

    The GSK threshold is the one people trip over, so check it first:

    • GSK Patient Assistance: a Medicare drug plan; income at or below $47,880 for one person or $64,920 for two in the 48 states and DC; and $600 already paid for prescriptions this calendar year.
    • TotalAssist (when open): government insurance covering Breo; income at or below 500% FPL adjusted for your regional cost-of-living index; a confirmed COPD or asthma diagnosis in treatment.
    • HealthWell (when open): insurance that covers part of the drug's cost, a prescriber-verified diagnosis, and treatment in the United States.
    • Extra Help: income below about $23,940 a year for one person or $32,460 for a couple, and countable resources limited to $18,090 or $36,100 in 2026.

  4. Step 4 — Gather your information

    Breo's application needs one document most others do not — proof of what you have already spent:

    • Medicare card and your Part D or Medicare Advantage drug-plan card, with policy ID and group number.
    • Your prescription spending so far this calendar year, for GSK's $600 threshold. Your plan's Explanation of Benefits statements or your pharmacy's year-to-date printout are the usual proof.
    • Household size and annual gross income, plus proof.
    • Your Breo Ellipta strength (50/25, 100/25 or 200/25 mcg) and whether it was prescribed for COPD or asthma — the funds are separate, and the answer decides which one you apply to.

  5. Step 5 — Complete the application

    Who fills out what:

    • GSK Patient Assistance: both you and your prescriber sign the enrollment form. Call 1-866-728-4368 if you need a form mailed.
    • Extra Help: you (or someone helping you) apply free through Social Security — online, by phone on 1-800-772-1213, or at an office. There is never a fee.
    • TotalAssist (when open): you apply online in about 15 minutes or by phone on 866-512-3861; Patient Advocate Foundation verifies the diagnosis with your provider.
    • HealthWell (when open): apply online or by phone; your provider verifies the diagnosis by signature.
    • Authorized generic: nothing to apply for — it is a prescribing and formulary question.

  6. Step 6 — Submit and wait for a determination

    What to expect:

    • GSK Patient Assistance: the foundation reviews income and insurance documentation; approved medicine is supplied through the program rather than your pharmacy.
    • Extra Help: Social Security notifies you by mail; your Part D plan then applies the lower copays.
    • TotalAssist (when open): an immediate online decision, with proof of income due within 30 days of approval.
    • HealthWell (when open): a decision once your provider returns the diagnosis verification.

  7. Step 7 — If the program is closed or you don't qualify

    Breo has more fallbacks than most inhalers, and one of them arrives on a fixed date:

    • Ask about the authorized generic — Prasco labels fluticasone furoate and vilanterol inhalation powder, and a generic tier usually costs less than a brand tier.
    • Mark January 1, 2027: Medicare's negotiated maximum fair price of $67.00 per 30-day equivalent supply takes effect for Part D plans.
    • If the $600 threshold is what is blocking you, note that it is a calendar-year test — it resets, and it is easier to meet later in the year than in January.
    • Ask your prescriber whether a different maintenance inhaler suits you. This is a clinical decision, not a cost one, so it needs their judgement.
    • Use the Medicare Prescription Payment Plan to spread this year's out-of-pocket costs across monthly payments.
    • Call AltaMedicare — we will work through every route above with you, free.

What you'll need

Only items the programs above actually ask for. Gather these before you start.

  • Medicare card and your Part D or Medicare Advantage drug-plan card — plan name, member ID and group number
  • Prescription details — medication name, strength and dose; prescriber name, office phone and address
  • Diagnosis and date of diagnosis — TotalAssist needs the exact date if diagnosed within the past 6 months
  • Household size and annual household income — and proof — tax return, Social Security or pension statements, or pay stubs
  • Proof of prescription spending this calendar year — GSK's Medicare route for Breo requires $600 already paid — plan Explanation of Benefits statements or a pharmacy year-to-date printout
  • Your Breo Ellipta strength — 50/25, 100/25 or 200/25 mcg — and whether it was prescribed for COPD or asthma

If assistance is unavailable

A closed fund or a denial is not the end of the road. Check these next:

  1. Ask your prescriber and plan about the authorized generic: DailyMed labels fluticasone furoate and vilanterol inhalation powder from Prasco Laboratories alongside GSK's brand.
  2. Medicare's negotiated maximum fair price for Breo Ellipta — $67.00 per 30-day equivalent supply — takes effect January 1, 2027 for Part D plans. CMS negotiated prices
  3. Sign up for TotalAssist fund notifications so you hear the moment a Breo Ellipta fund reopens — there is no waitlist or queue, so speed matters. TotalAssist notifications
  4. Sign up for HealthWell fund alerts for the same reason; HealthWell says closed funds reopen as funding is replenished. HealthWell disease funds
  5. Check Medicare Extra Help — it does not depend on a fund balance and lowers the cost of every covered drug, not just this one. Medicare Extra Help explained
  6. Ask your doctor's office — many practices have staff who handle assistance applications routinely and can request a formulary exception or a lower-cost alternative.
  7. Use the Medicare Prescription Payment Plan to spread this year's out-of-pocket costs across monthly payments (it does not lower the total). Medicare.gov
  8. Compare Part D and Medicare Advantage drug plans during the fall enrollment period — the tier and cost-sharing for Breo Ellipta differ from plan to plan. Compare Part D plan options

Could Medicare Extra Help reduce your Breo Ellipta costs?

Extra Help is not a grant for Breo Ellipta. It is a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription — so it is worth checking even when a charitable fund is closed, because it does not depend on fund balances.

Extra Help interacts with the GSK program in a way worth understanding before you apply to either. GSK's Medicare route for Breo does not exclude Extra Help enrollees — the $600 prescription-spending threshold is what governs — so unlike some manufacturer programs there is no penalty for holding both. Apply for Extra Help on its own merits: it lowers the cost of every covered drug you take, not just this one, and with full Extra Help a covered brand-name drug costs about $12.65 in 2026.

In 2026, people with full Extra Help generally pay no more than $12.65 for a covered brand-name drug. Income must be below about $23,940 a year for one person ($32,460 for a couple) and countable resources under $18,090 ($36,100 for a couple). Apply free through Social Security — online, by phone at 1-800-772-1213, or in person — and never pay anyone to apply for you.

Extra Help explained · Medicare Savings Programs · Estimate your drug costs · Free prescription cost review

Government program

Medicare Extra Help (Part D Low-Income Subsidy)

Medicare / Social Security Administration

Accepting applications Medicare: may apply

Status: Year-round federal program (figures for 2026)

Not a grant for one drug — a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription.

If you have Medicare: For people with Medicare Part D or a Medicare Advantage drug plan who have limited income and resources.

What it can cover: Part D premium and deductible (often to $0) and reduced copays — generally no more than $12.65 for a covered brand-name drug in 2026 with full Extra Help.

Who may qualify

  • Income below 150% of the federal poverty level — about $23,940 a year for one person or $32,460 for a married couple in 2026.
  • Countable resources (savings, investments — not your home or car) limited to $18,090 for an individual or $36,100 for a married couple living together in 2026 (Medicare.gov figures, which include a burial-expense allowance).
  • Automatic if you have Medicaid, Supplemental Security Income (SSI), or a Medicare Savings Program.

What the application asks for

  • Social Security number and Medicare number
  • Income (Social Security, pensions, wages) for you and a spouse you live with
  • Value of savings, investments and other countable resources

How to apply

You (or someone helping you) apply free through Social Security — online, by phone, or at a Social Security office. There is never a fee to apply.

Apply for Extra Help at SSA.gov → 1-800-772-1213

Key terms on this page

Patient assistance program (PAP)
A manufacturer program that provides its medication free or at low cost to people who meet income and insurance rules. Many PAPs accept Medicare Part D enrollees; each sets its own criteria.
Copay card / savings card
A manufacturer discount for commercially insured patients. Federal anti-kickback rules mean these cards generally cannot be used with Medicare, Medicaid or other government insurance.
Charitable copay grant
Money from a nonprofit foundation (for example HealthWell or Patient Advocate Foundation) that pays eligible copays or coinsurance for a specific diagnosis. A drug can be listed while the fund is closed to new applicants.
Federal poverty level (FPL)
A federal income measure that assistance programs use as a yardstick — "300% of FPL", "500% of FPL". The percentage is a rule, but the dollar figure behind it comes from a table each program publishes itself, built on a chosen year of the HHS poverty guidelines. Two programs can quote the same percentage in the same year and still list different dollar limits; compare each program against its own table, not against another program.
Medicare Extra Help
The Part D Low-Income Subsidy: a Medicare program that lowers or eliminates Part D premiums, deductibles and copays for beneficiaries with limited income and resources. You apply through Social Security.
Maximum Fair Price (MFP)
The price Medicare negotiated for a selected drug under the Medicare Drug Price Negotiation Program. It applies to Part D plans, not to the pharmacy cash price, and it lowers what plans and enrollees pay for that drug.

Related medication assistance guides

Trelegy Ellipta Assistance & Grants fluticasone furoate / umeclidinium / vilanterol Anoro Ellipta Assistance & Grants umeclidinium / vilanterol Incruse Ellipta Assistance & Grants umeclidinium Symbicort Assistance & Grants budesonide / formoterol fumarate dihydrate All prescription assistance Directory & program finder
Common Questions

Breo Ellipta assistance FAQ

Does Medicare cover Breo Ellipta?
Yes — Medicare Part D and Medicare Advantage drug plans generally cover Breo Ellipta, usually on a brand tier and sometimes behind step therapy. Part D out-of-pocket costs are capped at $2,100 in 2026. From January 1, 2027 a Medicare-negotiated maximum fair price of $67.00 per 30-day equivalent supply applies to Part D plans. If your income and resources are limited, Medicare Extra Help can bring a covered brand-name copay to about $12.65.
Is there a Breo Ellipta patient assistance program for people on Medicare?
Yes. Breo Ellipta is on the GSK Patient Assistance Program's published list of eligible products, and the program has a Medicare route. The condition people miss is the spending threshold: for GSK's "general" category of medicines, which includes Breo, you must have "paid a total of $600 for prescriptions in the current calendar year". You also need a Medicare drug plan and income at or below $47,880 for one person in the 48 states and DC. Both you and your prescriber sign the form.
Why does Nucala have different GSK rules from Breo Ellipta?
Because GSK sorts its medicines into categories and applies different Medicare rules to each. Breo Ellipta is a "general" product, which carries the $600 prescription-spending threshold and a $47,880 income limit for one person. Nucala is a "specialty" product: it has no spending threshold and a higher income limit of $63,840, but it excludes anyone enrolled in Medicare Extra Help. Same foundation, same application line, genuinely different rules — so check the rule for your own medicine rather than the one a friend was told.
Is Breo Ellipta part of Medicare drug price negotiation?
Yes. Breo Ellipta is one of the 15 drugs CMS selected for the second cycle of negotiation. CMS's selected-drug file gives it a single maximum fair price of $67.00 per 30-day equivalent supply, effective January 1, 2027. That price applies to Part D plans and the people enrolled in them — it is not a pharmacy cash price, and it does not change what you pay before 2027. CMS also publishes an explanation of how the price was reached.
Is there a generic for Breo Ellipta?
There is an authorized generic. DailyMed lists three labelled fluticasone furoate and vilanterol products across two labelers: GSK's Breo Ellipta, GSK's Trelegy Ellipta (which adds a third ingredient), and "Fluticasone Furoate and Vilanterol Powder" from Prasco Laboratories. Whether it saves you money depends on your plan's formulary, so ask your prescriber and your plan directly.
Is there a charitable grant for Breo Ellipta right now?
Not when we checked on August 26, 2026. Because Breo is licensed for both COPD and asthma it appears on more fund lists than most inhalers — TotalAssist's COPD fund, Asthma fund and the health-equity version of each, all closed at $1,200 guaranteed and $3,500 maximum, and HealthWell's Asthma and COPD – Medicare Access funds, also closed. Good Days has no respiratory fund. Six closed funds is worth setting alerts on, but plan around the GSK program and the generic rather than waiting. See all prescription assistance options.

Sources

Related resources

Assistance information last verified August 2026. Program details — fund status, eligibility, prices, phone numbers — change often; confirm with each program before applying. AltaMedicare does not administer, fund or approve any assistance program. Not medical advice.

Having trouble figuring out your prescription costs?

Bret can help you understand your Medicare prescription coverage and where to look for Breo Ellipta assistance — free, no pressure. We don't award grants or decide eligibility; the programs above do. We help you find and apply to the right ones.

Text Bret About Breo Ellipta Call (435) 292-5548